Summit Therapeutics (SMMT) News Today $24.39 +1.23 (+5.31%) (As of 09/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 Time Period Summit Therapeutics (NASDAQ:SMMT) Trading 4.2% Higher Summit Therapeutics (NASDAQ:SMMT) Trading Up 4.2%September 20 at 12:28 PM | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Stock Price Down 2.4%September 20 at 6:36 AM | americanbankingnews.comIs It Too Late to Buy Summit Therapeutics Stock After Its Almost 10X Gain This Year?September 19 at 5:50 AM | fool.comSmart Money Is Betting Big In SMMT OptionsSeptember 18 at 3:14 PM | benzinga.comThis Company Generates No Revenue and Its Market Cap Is Over $20 Billion. Here's Why That Valuation May Not Be All That Ridiculous.September 18 at 9:53 AM | fool.comBank of New York Mellon Corp Cuts Position in Summit Therapeutics Inc. (NASDAQ:SMMT)Bank of New York Mellon Corp lessened its holdings in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) by 7.1% during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 280,365 shares of the company's stock after selling 21,September 18 at 3:04 AM | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Sets New 12-Month High After Analyst UpgradeSeptember 18 at 1:23 AM | americanbankingnews.comSummit Therapeutics (NASDAQ:SMMT) Shares Gap Down to $29.48Summit Therapeutics (NASDAQ:SMMT) Shares Gap Down to $29.48September 17 at 1:13 PM | marketbeat.comSummit Therapeutics Inc. (NASDAQ:SMMT) Shares Bought by Sargent Investment Group LLCSargent Investment Group LLC increased its holdings in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) by 620.0% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 72,000 shares of the company's stSeptember 17 at 7:26 AM | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Given New $45.00 Price Target at HC WainwrightSeptember 17 at 4:45 AM | americanbankingnews.comHere's Why Everyone's Talking About Summit TherapeuticsSeptember 17 at 4:24 AM | fool.comSummit Therapeutics Share Chat (SMMT.US)September 16, 2024 | lse.co.ukInsider Buying: Summit Therapeutics Co-CEO & Executive Chairman Bought US$75m Of SharesSeptember 16, 2024 | finance.yahoo.comSummit Therapeutics (NASDAQ:SMMT) Reaches New 12-Month High on Analyst UpgradeSummit Therapeutics (NASDAQ:SMMT) Reaches New 52-Week High After Analyst UpgradeSeptember 16, 2024 | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) PT Raised to $45.00HC Wainwright upped their price target on shares of Summit Therapeutics from $30.00 to $45.00 and gave the stock a "buy" rating in a research note on Monday.September 16, 2024 | marketbeat.comPrincipal Financial Group Inc. Purchases 20,553 Shares of Summit Therapeutics Inc. (NASDAQ:SMMT)Principal Financial Group Inc. grew its position in shares of Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) by 131.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 36,133 shares of the company's sSeptember 15, 2024 | marketbeat.comIs Summit Therapeutics Inc. (NASDAQ:SMMT) an Unstoppable Growth Stock To Buy Now?September 15, 2024 | msn.comTD Asset Management Inc Invests $2.08 Million in Summit Therapeutics Inc. (NASDAQ:SMMT)TD Asset Management Inc purchased a new stake in shares of Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 266,800 shares of the company's stoSeptember 14, 2024 | marketbeat.comWhy Summit Therapeutics Skyrocketed 123% This WeekSeptember 13, 2024 | finance.yahoo.comHere's How Much $100 Invested In Summit Therapeutics 5 Years Ago Would Be Worth TodaySeptember 13, 2024 | benzinga.comSummit Therapeutics (NASDAQ:SMMT) Shares Up 9.4%Summit Therapeutics (NASDAQ:SMMT) Shares Up 9.4%September 13, 2024 | marketbeat.comSummit Therapeutics Raises $235 Mln In Private Placement; Stock Up In Pre-marketSeptember 12, 2024 | markets.businessinsider.comWhy Summit Therapeutics (SMMT) Stock Is Rising TodaySeptember 12, 2024 | msn.comSummit Therapeutics (NASDAQ:SMMT) Shares Gap Up to $22.70Summit Therapeutics (NASDAQ:SMMT) Shares Gap Up to $22.70September 12, 2024 | marketbeat.comWhy Summit Therapeutics Stock Is Soaring Again TodaySeptember 12, 2024 | fool.comSummit Therapeutics Surges on Trial Results: Time to Buy? (SMMT)Summit Therapeutics has surged almost 100% this week, driven by positive Phase III trial results for its cancer therapy Ivonescimab.September 12, 2024 | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Stock, Insider Trading ActivitySeptember 11, 2024 | benzinga.comSummit Therapeutics (NASDAQ:SMMT) PT Raised to $19.00 at CitigroupSeptember 11, 2024 | americanbankingnews.comSummit Therapeutics (NASDAQ:SMMT) PT Raised to $30.00 at HC WainwrightSeptember 11, 2024 | americanbankingnews.comSummit Therapeutics (NASDAQ:SMMT) PT Raised to $25.00 at Stifel NicolausSeptember 11, 2024 | americanbankingnews.comSummit Therapeutics Inc. (NASDAQ:SMMT) Shares Sold by Zurcher Kantonalbank Zurich CantonalbankZurcher Kantonalbank Zurich Cantonalbank reduced its stake in Summit Therapeutics Inc. (NASDAQ:SMMT - Free Report) by 82.7% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,760 shares of the cSeptember 11, 2024 | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Sees Large Volume Increase After Analyst UpgradeSeptember 11, 2024 | americanbankingnews.comSummit Therapeutics (NASDAQ:SMMT) Sees Strong Trading Volume After Analyst UpgradeSummit Therapeutics (NASDAQ:SMMT) Sees Strong Trading Volume After Analyst UpgradeSeptember 10, 2024 | marketbeat.comSummit shares hit record high as cancer drug tops Keytruda in China trialSeptember 10, 2024 | reuters.comSummit Therapeutics: World Lung Data Not Enough For Ivonescimab To Unseat Keytruda (Yet)September 10, 2024 | seekingalpha.comIs Summit Therapeutics a Buy Now?September 10, 2024 | fool.comWhy Summit Therapeutics Rocketed Over 60% TodaySeptember 9, 2024 | fool.comSummit Therapeutics (NASDAQ:SMMT) Price Target Increased to $19.00 by Analysts at CitigroupCitigroup boosted their price objective on shares of Summit Therapeutics from $13.00 to $19.00 and gave the stock a "buy" rating in a research report on Monday.September 9, 2024 | marketbeat.comLung Cancer Drug Trial News Has Summit Therapeutics Stock Up 40% TodaySeptember 9, 2024 | investopedia.comSummit Therapeutics (NASDAQ:SMMT) Reaches New 12-Month High After Analyst UpgradeSummit Therapeutics (NASDAQ:SMMT) Sets New 52-Week High Following Analyst UpgradeSeptember 9, 2024 | marketbeat.comSummit Therapeutics' Lung Cancer Candidate Surpasses Merck's Multi-Billion Dollar Keytruda, Cuts Risk Of Disease Or Death By HalfSeptember 9, 2024 | benzinga.comSMMT Jan 2025 6.000 callSeptember 9, 2024 | ca.finance.yahoo.comSummit Therapeutics (NASDAQ:SMMT) Rating Reiterated by HC WainwrightHC Wainwright restated a "buy" rating and issued a $16.00 price objective on shares of Summit Therapeutics in a research report on Tuesday.September 3, 2024 | marketbeat.comSummit Therapeutics (NASDAQ:SMMT) Trading Down 2.6%Summit Therapeutics (NASDAQ:SMMT) Shares Down 2.6%August 30, 2024 | marketbeat.comSMMT Sep 2024 19.000 callAugust 30, 2024 | ca.finance.yahoo.comS&P 500 Futures Climb in Premarket Trading; Summit Therapeutics, Liberty Formula One C LeadAugust 26, 2024 | marketwatch.comAkeso, Inc. (AKESF)August 24, 2024 | au.finance.yahoo.comSummit Therapeutics (NASDAQ:SMMT) Shares Down 2.7% Summit Therapeutics (NASDAQ:SMMT) Shares Down 2.7%August 23, 2024 | marketbeat.comSummit Therapeutics Share Price (SMMT.US)August 21, 2024 | lse.co.ukSummit Therapeutics (NASDAQ:SMMT) Trading 3% Higher Summit Therapeutics (NASDAQ:SMMT) Stock Price Up 3%August 20, 2024 | marketbeat.com Get Summit Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SMMT and its competitors with MarketBeat's FREE daily newsletter. Email Address Forget Trump and Kamala (Ad)Forget Trump and Kamala. I don't care who you vote for - This calendar is the only thing that matters right now. Download my Dividend Calendar here SMMT Media Mentions By Week SMMT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SMMT News Sentiment▼0.690.49▲Average Medical News Sentiment SMMT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SMMT Articles This Week▼213▲SMMT Articles Average Week Get Summit Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SMMT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Takeda Pharmaceutical News Today Moderna News Today BioNTech News Today Teva Pharmaceutical Industries News Today BeiGene News Today Genmab A/S News Today Viatris News Today Dr. Reddy's Laboratories News Today Vaxcyte News Today Sarepta Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SMMT) was last updated on 9/20/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s “Tax Free” Retirement StrategySince 1924 — over one hundred years — the US dollar has lost nearly 18x its value. If you're planning on re...Gold Safe Exchange | SponsoredThe election trade you can't losePolitics is an unpredictable game. But no matter what happens in the next few months... There's one thin...Investors Alley | SponsoredAre You Ready for a Small-Cap Rally?Jeff Bezos has just made a bold move into Quantum Computing as a Service (QaaS), a technology set to disrupt i...InvestorPlace | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredMust-Know for Trading OptionsOptions are becoming increasingly popular among investors – with demand hitting record highs for 3 years in a ...Unstoppable Prosperity | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredUnlock the Secret to Easy Wins with Iron CondorsDiscover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...Netpicks | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Summit Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Summit Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
